Form D · Other
Salvo Health, Inc.
New York, NY · CIK 0002013278
Offering snapshot reported Dec 30, 2025 · SEC filing
- Reported sold
- $9.45M Offering amount: $11.7M
- Investors reported
- 31 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 15, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 30, 2025 | Initial | $9,452,701 | No comparison | 31 | SEC filing |
| Feb 29, 2024 | Initial | $15,074,999 | No comparison | 23 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-568438
Total Offering Amount and Total Amount Sold include $4,744,694 previously received by the issuer in the sale of convertible notes that converted in this round.
Source: Form D, filed Dec 30, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Josh Cohen | Director |
| Jeffrey S. Glueck | Director, Executive, Promoter |
| Emily Melton | Director |
| Rachel Parlier | Director |
Issuer details
Industry: Other (See others in industry)
Address:
C/O We Work 450 Lexington Avenue, 4th Floor
New York, NY, 10017
New York, NY, 10017